心房細動を患っている高齢者の血栓や出血を 減らすにはどうすればいいのでしょうか?
Ilaria Maria Palumbo1, Tommaso Bucci2,3, Danilo Menichelli1
1Department of General and Specialistic Surgery, Sapienza University of Rome, Rome, Italy.
Expert review of cardiovascular therapy
|August 22, 2025
まとめ
心房細動 (AF) の高齢者の心血管疾患の管理には,脳卒中と出血のリスクのバランスをとる必要があります. このレビューでは,脆弱なAF患者の統合ケアのための戦略を概説し,結果を最適化します.
科学分野:
- 心臓病科
- 高齢者医療
- 薬理学について
背景:
- 平均寿命が伸びているため 年齢関連の心血管疾患が増加しています
- 心血管疾患の高齢者はしばしば多発性,多薬性,および弱さを示し,管理を複雑にし,リスクを増加させます.
- 心房細動 (AF) は,高齢者集団で増加する頻度で,血栓塞栓性イベントの重大なリスクを伴います.
研究 の 目的:
- AFの高齢患者の血栓不全と出血のリスクを管理するための戦略をレビューする.
- 複雑で脆弱なAF患者の統合的・総合的な管理方法を強調する.
主な方法:
- このレビューは,高齢者のAF管理に関する現在の証拠と専門家の意見をまとめています.
- この集団における口服抗凝固剤 (OAC) 治療の利点と出血のリスクのバランスを取ることに焦点を当てています.
主要な成果:
- 高齢のAF患者は,OACによる脳卒中の予防と,併発性疾患による高血症の管理の間の微妙なバランスに直面しています.
- 統合された総合的なアプローチは,弱い個体における臨床的利益の最適化に不可欠です.
結論:
- 高齢者のAFの有効な管理には,抗血栓効果と出血の懸念を慎重に考慮する個別化されたアプローチが必要です.
- 脆弱な高齢のAF患者の治療結果を改善するためには 統合されたケアモデルが不可欠です
関連する概念動画
Venous Thrombosis III: Interprofessional Care
22
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
22
Venous Thrombosis IV: Nursing Management
23
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
23
Atherosclerosis III: Management
33
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
33
Anticoagulant Drugs: Low-Molecular-Weight Heparins
893
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
893
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.3K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K
Peripheral Artery Disease III: Interprofessional Care
29
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
29


